Franklin Resources
GPCR icon

Franklin Resources’s Structure Therapeutics GPCR Stock Holding History

Franklin Resources’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1M Buy
578,839
+47,244
+9% +$2.09M 0.01% 848
2026
Q1 		$25.6M Sell
531,595
-338,987
-39% -$23.2M 0.01% 894
2025
Q4 		$60.5M Buy
870,582
+124,848
+17% +$5.1M 0.01% 583
2025
Q3 		$20.9M Buy
745,734
+3,951
+0.5% +$78.7K 0.01% 937
2025
Q2 		$15.4M Buy
741,783
+1,631
+0.2% +$35.9K ﹤0.01% 1006
2025
Q1 		$12.8M Buy
740,152
+2,062
+0.3% +$50.5K ﹤0.01% 1029
2024
Q4 		$20M Buy
738,090
+31,984
+5% +$1.13M 0.01% 914
2024
Q3 		$25.9M Buy
706,106
+60,397
+9% +$2.34M 0.01% 814
2024
Q2 		$25.4M Buy
645,709
+109,962
+21% +$4.52M 0.01% 776
2024
Q1 		$23M Sell
535,747
-6,576
-1% -$277K 0.01% 822
2023
Q4 		$22.1M Buy
542,323
+291,503
+116% +$16.7M 0.01% 734
2023
Q3 		$12.6M Buy
250,820
+11
+0% +$354 0.01% 860
2023
Q2 		$10.4M Sell
250,809
-74,191
-23% -$2.08M 0.01% 909
2023
Q1 		$7.73M Buy
+325,000
New +$7.64M ﹤0.01% 988

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources's GPCR Position: Q2 2026 in Review

Franklin Resources increased its Structure Therapeutics (GPCR) stake by 8.9% in Q2 2026, buying an estimated $2.09M and bringing the position to 578,839 shares worth $31.1M. The position accounts for 0.01% of the portfolio, ranked #848.

Franklin Resources first reported a position in GPCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $60.5M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Franklin Resources held 578,839 shares of Structure Therapeutics worth $31.1M as of Q2 2026.
  • Franklin Resources bought 47,244 Structure Therapeutics shares in Q2 2026, an estimated $2.09M.
  • Structure Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #848 holding.
  • Franklin Resources first reported a position in Structure Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Franklin Resources's Structure Therapeutics position peaked at $60.5M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.